LDR | |
01058nas a2200277 a 4500 |
001 |
|
010586950 |
003 |
|
MiAaHDL |
005 |
|
20110720000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
970701c19859999iluar c 0 a0eng d |
035 |
⊔ |
⊔ |
‡asdr-inu1022451
|
035 |
⊔ |
⊔ |
‡a(OCoLC)25959673
|
040 |
⊔ |
⊔ |
‡aNDL
‡cNDL
‡dGAO
|
043 |
⊔ |
⊔ |
‡an-us---
|
050 |
⊔ |
4 |
‡aRM301.45
‡b.A67
|
245 |
0 |
0 |
‡aApproved drug products with therapeutic equivalence evaluations /
‡cissued by the Food and Drug Administration.
|
260 |
⊔ |
⊔ |
‡aChicago, Ill. :
‡bCommerce Clearing House,
‡c[1985?]-
|
300 |
⊔ |
⊔ |
‡av. ;
‡c23 cm.
|
310 |
⊔ |
⊔ |
‡aAnnual
|
500 |
⊔ |
⊔ |
‡aDescription based on: 12th ed. (1992)
|
500 |
⊔ |
⊔ |
‡a"Food Drug Cosmetic Law Reports. Extra edition."--Cover.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aMedical care
‡zUnited States
‡xPeriodicals.
|
650 |
⊔ |
0 |
‡aPharmaceutical services insurance
‡xPeriodicals.
|
650 |
⊔ |
0 |
‡aDrugs
‡xCatalogs
‡xPeriodicals.
|
650 |
⊔ |
0 |
‡aDrugs
‡xBioavailability
‡xPeriodicals.
|
650 |
⊔ |
0 |
‡aDrugs
‡xTherapeutic equivalency
‡xPeriodicals.
|
710 |
2 |
⊔ |
‡aCenter for Drug Evaluation and Research (U.S.)
|
CID |
⊔ |
⊔ |
‡a010586950
|
DAT |
0 |
⊔ |
‡a20110720093204.0
‡b20110720000000.0
|
DAT |
1 |
⊔ |
‡a20120814120853.0
‡b2023-11-14T18:30:44Z
|
CAT |
⊔ |
⊔ |
‡aSDR-INU
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aSE
|
HOL |
⊔ |
⊔ |
‡0sdr-inu1022451
‡ainu
‡bSDR
‡cINU
‡pinu.30000043148521
‡sINU
‡11022451
|
974 |
⊔ |
⊔ |
‡bINU
‡cINU
‡d20231114
‡sgoogle
‡uinu.30000043148521
‡rund
‡qbib
‡tUS bib date2 >= 1929
|
974 |
⊔ |
⊔ |
‡bINU
‡cINU
‡d20240130
‡sgoogle
‡uinu.30000043148539
‡rund
‡qbib
‡tUS bib date2 >= 1929
|
974 |
⊔ |
⊔ |
‡bINU
‡cINU
‡d20231114
‡sgoogle
‡uinu.30000043148547
‡rund
‡qbib
‡tUS bib date2 >= 1929
|
974 |
⊔ |
⊔ |
‡bINU
‡cINU
‡d20240222
‡sgoogle
‡uinu.30000043148497
‡rund
‡qbib
‡tUS bib date2 >= 1929
|
974 |
⊔ |
⊔ |
‡bINU
‡cINU
‡d20240130
‡sgoogle
‡uinu.30000052805417
‡rund
‡qbib
‡tUS bib date2 >= 1929
|